|
|
| (18 intermediate revisions not shown.) |
| Line 1: |
Line 1: |
| - | [[Image:3hei.png|left|200px|thumb|Crystal Structure of ephrin A2 receptor complex with ephrin, [[3hei]]]]
| + | <StructureSection load='' size='350' side='right' scene='45/450911/Cv/1' caption='Human ephrin A3 receptor (magenta) complex with peptide substrate (green), nucleotide derivative and Mg+2 ion [[3fxx]]'> |
| - | {{STRUCTURE_3fxx| PDB=3fxx | SIZE=300| SCENE= |right|CAPTION=Human ephrin A3 receptor (grey) complex with peptide substrate (green), nucleotide derivative (stick model) and Mg+2 ion [[3fxx]] }}
| + | |
| | | | |
| - | '''Ephrin receptors''' (EPHR) are components of the cell signaling pathways. They belong to the receptor tyrosine kinases. The extracellular ligand-binding domain (LBD) interacts with ephrin. EPHR domains include an ectodomain (residues 23-435) containing the LBD (residues 23-326), a second fibronectin III domain (fn3) (residues 446-539), a transmembrane domain (residues 539-563), a kinase domain (residues 596-900) and a sterile-α-motif (SAM) domain (residues 908-972). For more details see [[ Ephrin Type-A Receptor]].
| + | == Function == |
| | | | |
| | + | '''Ephrin receptors''' (EPHR) are components of the cell signaling pathways. They belong to the [[receptor tyrosine kinases]]. The extracellular ligand-binding domain (LBD) interacts with ephrin<ref>PMID:21078817</ref>. For more details see [[Ephrin Type-A Receptor]] and [[Kinase-linked, enzyme-linked and related receptors]]. |
| | + | . |
| | | | |
| | + | ==Relevance == |
| | | | |
| | + | EPHR and ephrins can act as both tumor suppressors and tumor enhancers depending on the context<ref>PMID:20810264</ref>. |
| | | | |
| | + | == Structural highlights == |
| | | | |
| | + | EPHR domains include an ectodomain (residues 23-435) containing the LBD (residues 23-326), a second fibronectin III domain (fn3) (residues 446-539), a transmembrane domain (residues 539-563), a kinase domain (residues 596-900) and a sterile-α-motif (SAM) domain (residues 908-972). |
| | | | |
| | + | <scene name='45/450911/Cv/8'>Ephrin A3 receptor with peptide substrate, nucleotide derivative and Mg+2 ion</scene>. Water molecules are shown as red spheres. |
| | | | |
| | + | <scene name='45/450911/Cv/9'>Nucleotide derivative and Mg+2 ion binding site</scene>. |
| | | | |
| | + | <scene name='45/450911/Cv/10'>Peptide substrate binding site</scene> ([[3fxx]]).<ref>PMID:19678838</ref> |
| | | | |
| | + | == 3D Structures of ephrin receptor == |
| | + | [[Ephrin receptor 3D structures]] |
| | | | |
| | + | </StructureSection> |
| | | | |
| - | | + | == References == |
| - | | + | <references/> |
| - | | + | |
| - | | + | |
| - | == 3D Structures of ephrin receptors == | + | |
| - | | + | |
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
| + | |
| - | {{#tree:id=OrganizedByTopic|openlevels=0|
| + | |
| - | | + | |
| - | *Ephrin A1 receptor
| + | |
| - | **[[3kka]] - hEPHR A1 SAM+ hEPH A2 SAM – human<BR />
| + | |
| - | **[[3hil]] - hEPHR A1 SAM<br />
| + | |
| - | **[[2k1l]] - hEPHR A1 transmembrane domain – NMR<BR />
| + | |
| - | **[[1x5a]] - hEPHR A1 fn3 domain – NMR<BR />
| + | |
| - | *Ephrin A2 receptor
| + | |
| - | **[[3hpn]], [[3c8x]] - hEPHR A2 LBD<BR />
| + | |
| - | **[[2x10]], [[3fl7]] - hEPHR A2 ectodomain<BR />
| + | |
| - | **[[2k9y]], [[2e8n]] - hEPHR A2 transmembrane domain – NMR<BR />
| + | |
| - | **[[1mqb]], [[4p2k]], [[4pdo]], [[4trl]] - hEPHR A2 kinase domain<BR />
| + | |
| - | | + | |
| - | *''Ephrin A2 receptor binary complex''<br />
| + | |
| - | | + | |
| - | **[[3mx0]], [[2x11]] - hEPHR A2 ectodomain + ephrin A5<BR />
| + | |
| - | **[[3hei]], [[3czu]] - hEPHR A2 LBD + ephrin A1<BR />
| + | |
| - | **[[3mbw]] - hEPHR A2 LBD + carbohydrate-recognition domain + ephrin A1<br />
| + | |
| - | **[[2kso]] - hEPHR A2 SAM + SHIP2<br />
| + | |
| - | *Ephrin A3 receptor
| + | |
| - | **[[2qo2]], [[2qob]], [[2gsf]] - hEPHR A3 kinase domain<BR />
| + | |
| - | **[[2qok]], [[2qol]], [[2qon]], [[2qoo]], [[2qod]], [[2qof]], [[2qoi]] - hEPHR A3 kinase domain (mutant) <BR />
| + | |
| - | **[[3fxx]], [[3fy2]] – hEPHR A3 kinase domain + peptide substrate<BR />
| + | |
| - | **[[2qoq]], [[2qo7]], [[2qo9]], [[2qoc]] - hEPHR A3 kinase domain + AMP-PNP<BR />
| + | |
| - | **[[3dzq]], [[4gk2]], [[4gk3]], [[4gk4]], [[4p5q]], [[4p5z]] - hEPHR A3 kinase domain + inhibitor<br />
| + | |
| - | **[[4g2f]] - hEPHR A3 kinase domain (mutant) + inhibitor<br />
| + | |
| - | *Ephrin A4 receptor
| + | |
| - | **[[2wo1]], [[3ckh]] - hEPHR A4 LBD<BR />
| + | |
| - | **[[4bk4]], [[4m4p]] - hEPHR A4 ectodomain<br />
| + | |
| - | **[[2lw8]] - hEPHR A4 LBD – NMR<br />
| + | |
| - | **[[2hel]] – mEPHR A4 membrane and kinase domains – mouse<br />
| + | |
| - | **[[2y6m]] – mEPHR A4 kinase domain<br />
| + | |
| - | | + | |
| - | *''Ephrin A4 receptor binary complex''<br />
| + | |
| - | | + | |
| - | **[[2wo3]] - hEPHR A4 LBD + ephrin A2 receptor-binding domain<BR />
| + | |
| - | **[[4w4z]], [[4w50]] - hEPHR A4 LBD (mutant) + peptide<br />
| + | |
| - | **[[2wo2]], [[3gxu]] - hEPHR A4 LBD + ephrin B2 receptor-binding domain<br />
| + | |
| - | **[[4bk5]], [[4bka]], [[4m4r]] - hEPHR A4 ectodomain + ephrin A5 LBD<br />
| + | |
| - | **[[4bkf]] - hEPHR A4 ectodomain + ephrin B3 LBD<br />
| + | |
| - | **[[2xyu]] – mEPHR A4 kinase domain + inhibitor<br />
| + | |
| - | **[[2y6o]] – mEPHR A4 kinase domain + cancer drug<br />
| + | |
| - | *Ephrin A5 receptor
| + | |
| - | **[[2r2p]] - hEPHR A5 kinase domain<BR />
| + | |
| - | **[[1shx]] - mEPHR A5 <br />
| + | |
| - | **[[4et7]] – hEPHR A5 (mutant)<br />
| + | |
| - | *Ephrin A7 receptor
| + | |
| - | **[[3nru]] – hEPHR A7 LBD<BR />
| + | |
| - | **[[3h8m]] – hEPHR A7 SAM<BR />
| + | |
| - | **[[2rei]] - hEPHR A7 kinase domain<BR />
| + | |
| - | **[[3dko]] – hEPHR A7 kinase domain + inhibitor
| + | |
| - | *Ephrin A8 receptor
| + | |
| - | **[[3kul]] - hEPHR A8 kinase domain<BR />
| + | |
| - | **[[1x5l]] – hEPHR A8 fn3 domain – NMR<BR />
| + | |
| - | **[[1ucv]] - hEPHR A8 SAM – NMR<BR />
| + | |
| - | *Ephrin B1 receptor
| + | |
| - | **[[2eao]] – hEPHR B1 SAM – NMR<BR />
| + | |
| - | **[[2djs]] - hEPHR B1 fn3 domain – NMR<BR />
| + | |
| - | **[[3zfx]] - hEPHR B1 kinase domain<br />
| + | |
| - | *Ephrin B2 receptor
| + | |
| - | **[[3etp]] – hEPHR B2<BR />
| + | |
| - | **[[1b4f]] - hEPHR B2 SAM<br />
| + | |
| - | **[[1f0m]] – mEPHR B2 SAM<BR />
| + | |
| - | **[[1iko]] - mEPHR B2 ectodomain<br />
| + | |
| - | **[[2i85]] - hEPHR B2 ectodomain<br />
| + | |
| - | **[[1sgg]] - mEPHR B2 SAM – chicken - NMR<BR />
| + | |
| - | | + | |
| - | *''Ephrin B2 receptor binary complex''<br />
| + | |
| - | | + | |
| - | **[[2vsk]], [[2vsm]] – hEPHR B2 + Viral Hemagglutinin-neuraminidase<BR />
| + | |
| - | **[[2qbx]] – hEPHR B2 + peptide agonist<BR />
| + | |
| - | **[[2hen]] - hEPHR B2 kinase domain + ADP<BR />
| + | |
| - | **[[1shw]] - mEPHR B2 LBD + ephrin A5<BR />
| + | |
| - | **[[1kgy]] - mEPHR B2 LBD + ephrin B2 extracellular domain<BR />
| + | |
| - | | + | |
| - | *Ephrin B3 receptor
| + | |
| - | **[[3p1i]] – hEPHR B3 LBD<BR />
| + | |
| - | **[[3zfy]] - hEPHR B3 kinase domain<br />
| + | |
| - | *Ephrin B4 receptor
| + | |
| - | **[[2qkq]] – hEPHR B4 SAM<BR />
| + | |
| - | **[[2e7h]] – hEPHR B4 fn3 domain - NMR<BR />
| + | |
| - | **[[2x9f]], [[2vwy]] - hEPHR B4 kinase domain (mutant) <BR />
| + | |
| - | | + | |
| - | *''Ephrin B4 receptor binary complex''<br />
| + | |
| - | | + | |
| - | **[[2vwx]], [[2vwz]], [[2vx0]], [[2vx1]], [[2vwu]], [[2vwv]], [[2vww]], [[4aw5]] – hEPHR B4 kinase domain + inhibitor <BR />
| + | |
| - | **[[3zew]] - hEPHR B4 + staurosporine<br />
| + | |
| - | **[[2xvd]], [[2yn8]], [[4bb4]] - hEPHR B4 kinase domain (mutant) + inhibitor<br />
| + | |
| - | **[[2hle]], [[2bba]] - hEPHR B4 LBD + ephrin B2
| + | |
| - | }}
| + | |
| - | | + | |
| - | | + | |
| - | | + | |
| - |
| + | |
| - | | + | |
| | | | |
| | [[Category:Topic Page]] | | [[Category:Topic Page]] |